Original Articles

Prevalence and clinical and evolutionary epidemiological profile of chikungunya cases during the first epidemic in Chad in 2020

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 23 March 2026
394
Views
210
Downloads

Authors

The emergence and re-emergence of infectious agents is a real threat to public health. In recent years, we have noticed a re-emergence of arboviruses, including chikungunya. In July 2020, Chad experienced its first confirmed outbreak of chikungunya in the Ouaddaï province, more precisely in the Abèche health district. The aim of this study is to determine the prevalence of chikungunya cases in the specified district and to describe their clinical characteristics and epidemiological progression. This cross-sectional study used an operational definition to identify chikungunya cases. Cluster sampling was employed to select participants. Relative frequencies related to sociodemographic characteristics, clinical data, knowledge, attitudes, and practices were calculated. In addition, the prevalence was estimated with its 95% confidence intervals (CI). The prevalence of chikungunya disease among people meeting the case definition was estimated at 78%. The most affected age group was 5-14 years (30%), followed by 15-24 years (27%). Females accounted for the majority of cases (54%). Clinically, fever and disabling arthralgia were found in 100% of respondents. Headaches were present in 87% of respondents. Gastrointestinal signs were dominated by vomiting (44%), and the most frequently reported cutaneous signs were rashes (22%) and pruritus (17%). A significant number of respondents had sought help from a traditional healer (26%). Of the 1,902 chikungunya cases, 1,781 (93%) reported persistent pain lasting more than 3 weeks, but of varying intensity. Chikungunya has a very low case-fatality rate, but a non-negligible impact on the health of the population. In our study, the high prevalence in the Abéché district testifies to the extent of the disease during the first epidemic. Better epidemiological surveillance, coupled with effective vector control, could prevent future epidemics in other towns in the country.

Downloads

Download data is not yet available.

Citations

1. de Lima Cavalcanti TYV, Pereira MR, de Paula SO, Franca RFO. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses 2022;14:969.
2. Weaver SC, Charlier C, Vasilakis N, Lecuit M. Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases. Annu Rev Med 2018;69:395 408.
3. Chang AY, Encinales L, Porras A, et al. Frequency of Chronic Joint Pain following Chikungunya Infection: A Colombian Cohort Study. Arthritis Rheumatol 2018;70:578-84.
4. Cunha RVD, Trinta KS. Chikungunya virus: clinical aspects and treatment - A Review. Mem Inst Oswaldo Cruz 2017;112:523-31.
5. Rama K, de Roo AM, Louwsma T, et al. Clinical outcomes of chikungunya: A systematic literature review and meta-analysis. PLoS Negl Trop Dis 2024;18:e0012254.
6. Costa LB, Barreto FKA, Barreto MCA, et al. Epidemiology and Economic Burden of Chikungunya: A Systematic Literature Review. Trop Med Infect Dis 2023;8:301.
7. Ministry of Public Health, Republic of Chad. [Epidemiological situation report of chikungunya in Chad No. 32, 2 October 2020 (23:59)] [Internet]. 2020. Available from: https://reliefweb.int/report/chad/rapport-de-la-situation-epidmiologique-chikungunya-au-tchad-n-32-02-octobre-2020-23h59
8. INSEED-Chad. Social and Demographic Statistics: Population. Available at: https://www.inseed.td/index.php/statistiques-sociales-et-demographiques
9. Konongoi SL, Nyunja A, Ofula V, et al. Human and entomologic investigations of chikungunya outbreak in Mandera, Northeastern Kenya, 2016. PLoS One 2018;13:e0205058.
10. Demanou M, Antonio-Nkondjio C, Ngapana E, et al. Chikungunya outbreak in a rural area of Western Cameroon in 2006: A retrospective serological and entomological survey. BMC Res Notes 2010;3:128.
11. World Health Organization. Chikungunya – Chad [Internet]. Geneva: WHO; 2020. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/chikungunyachad
12. Badawi A, Ryoo SG, Vasileva D, Yaghoubi S. Prevalence of chronic comorbidities in chikungunya: A systematic review and meta-analysis. Int J Infect Dis 2018;67:107-13.

How to Cite



Prevalence and clinical and evolutionary epidemiological profile of chikungunya cases during the first epidemic in Chad in 2020. (2026). Sahelian Journal of Responsible One Health, 2(1). https://doi.org/10.4081/sjroh.2026.612